Treating Adults Patients with Eosinophilic Esophagitis

Long-term data provide insights about esophageal dilation and other care strategies.

Eosinophilic esophagitis (EoE) used to be recognized only as a pediatric disease. Its prevalence in adults who present with dysphagia and, often, food bolus obstruction has become better known (JW Gastroenterol Mar 28 2006). Esophageal dilation is necessary in the majority of affected patients.

Researchers now present long-term treatment data from 16 consecutive adult patients (age range, 20–58; 75% men) who met diagnostic criteria for EoE, had detailed histories taken, and underwent baseline upper gastrointestinal endoscopy with multiple esophageal biopsies. Of these patients, 15 were receiving proton-pump inhibitor therapy, 13 underwent initial esophageal dilation, 1 was treated with a restrictive diet, and 1 received topical (swallowed) f…

Reviewing Author

David A. Johnson, MD

Disclosures

Consultant/Advisory boardMedscape/WebMD; Pfizer; CRH Medical Corporation; Aries

EquityCRH Medical Corporation

Editorial boardsMedscape Gastroenterology

Leadership positions in professional societiesAmerican College of Gastroenterology Research Institute Board of Directors